ID

24570

Beschreibung

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

Stichworte

  1. 06.08.17 06.08.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

6. August 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

COPD EXACERBATIONS
Beschreibung

COPD EXACERBATIONS

Alias
UMLS CUI-1
C0740304
Was there a COPD exacerbation?
Beschreibung

COPD exacerbation

Datentyp

text

Alias
UMLS CUI [1]
C0740304
If "yes" to COPD exacerbation, record following items.
Beschreibung

If "yes" to COPD exacerbation, record following items.

Alias
UMLS CUI-1
C0740304
Date of Onset
Beschreibung

date of onset of COPD exacerbation

Datentyp

date

Alias
UMLS CUI [1,1]
C0574845
UMLS CUI [1,2]
C0740304
Outcome
Beschreibung

outcome of COPD exacerbation

Datentyp

integer

Alias
UMLS CUI [1,1]
C0085565
UMLS CUI [1,2]
C0740304
Date of Resolution or Death
Beschreibung

date of resolution or death

Datentyp

date

Alias
UMLS CUI [1]
C2985858
UMLS CUI [2]
C1148348
Severity
Beschreibung

severity of COPD excerbation

Datentyp

integer

Alias
UMLS CUI [1,1]
C0439793
UMLS CUI [1,2]
C0740304
Was the subject withdrawn due to this exacerbation?
Beschreibung

Subjects who experience more than one moderate exacerbation requiring antibiotic and/or oral corticosteroid treatment during the treatment period and/or experience a severe exacerbation requiring hospitalisation during the course of the study must be withdrawn.

Datentyp

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0740304

Ähnliche Modelle

COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
COPD EXACERBATIONS
C0740304 (UMLS CUI-1)
Item
Was there a COPD exacerbation?
text
C0740304 (UMLS CUI [1])
Code List
Was there a COPD exacerbation?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
If "yes" to COPD exacerbation, record following items.
C0740304 (UMLS CUI-1)
date of onset of COPD exacerbation
Item
Date of Onset
date
C0574845 (UMLS CUI [1,1])
C0740304 (UMLS CUI [1,2])
Item
Outcome
integer
C0085565 (UMLS CUI [1,1])
C0740304 (UMLS CUI [1,2])
CL Item
Resolved (1)
CL Item
Fatal (2)
CL Item
Not resolved (3)
date of resolution or death
Item
Date of Resolution or Death
date
C2985858 (UMLS CUI [1])
C1148348 (UMLS CUI [2])
Item
Severity
integer
C0439793 (UMLS CUI [1,1])
C0740304 (UMLS CUI [1,2])
CL Item
moderate (2)
CL Item
severe (3)
Item
Was the subject withdrawn due to this exacerbation?
text
C0422727 (UMLS CUI [1,1])
C0740304 (UMLS CUI [1,2])
Code List
Was the subject withdrawn due to this exacerbation?
CL Item
Yes (Y)
CL Item
No (N)

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video